Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis.

ABSTRACT:

Background

Although depression and anxiety represent significant yet treatable comorbidities in patients with idiopathic pulmonary fibrosis (IPF), their impact on the clinical course and prognosis of IPF remain unclear.

Purpose

We investigated the prevalence and clinical significance of depression and anxiety in patients with IPF.

Methods

The present study included a prospective cohort comprising 112 Korean patients with IPF who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire.

Results

Symptoms of depression and anxiety were present in 25.9% and 21.4% of patients with IPF, respectively (HADS scores ≥8). No significant differences in demographic data, age, sex, smoking status, Modified Medical Research Council Dyspnea Scale (MMRC) sco

SUBMITTER: Lee YJ 

PROVIDER: S-EPMC5593186 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature